Clinical Trial Resource Center
Welcome to the National Pancreas Foundation Clinical Trials Resource Center, presented in partnership with CenterWatch, the leading publisher of information on clinical research for patients, their advocates and healthcare professionals. Please click on the links below to learn more about clinical research and about new medical therapies for treating pancreas disease and related indications.
This section provides background information about the clinical trials process and what to expect when you volunteer to participate in a clinical trial. Here, you’ll find answers to frequently asked questions about clinical trials and also suggestions for where to find more information.
Listing of Clinical Trials
TITLE: A Phase 2, randomized, DOUBLE-BLIND, PARALLEL‑GROUP dose-ranging STUDY TO EVALUATE THE Safety and efficacy OF Ni-03 compared to placebo in subjects with chronic pancreatitis (Phase II Clinical Trial for Chronic Pancreatitis Pain)
This is a multicenter, randomized, double-blind, placebo controlled study of three doses of NI-03. The aim of the study is to evaluate if the drug is effective in treating the acute symptoms of chronic pancreatitis when given for 4 weeks. For more information, please CLICK HERE.
This is a listing of U.S. and international clinical trials actively recruiting patients for indications related to pancreas disease. Use this listing to search for clinical trials by geographic region. Please check back regularly since this database is updated daily.
TITLE: ISIS 304801-CS7 The APPROACH Open Label Study Volanesorsen (ISIS 304801) An Open-Label Study of Volanesorsen Administered Subcutaneously to Patients With Familial Chylomicronemia Syndrome (FCS) (Phase III Clinical Trial for Familial Chylomicronemia Syndrome (FCS)
This is a multi-center, open-label study. All patients will receive volanesorsen 300 mg once per week for 52 weeks. Patients will have the option of continuing dosing for an additional 52 weeks until an expanded access program is approved and available in their country. For more information, please CLICK HERE.
TITLE: Statin Therapy to Reduce the Risk of Recurrent Pancreatitis
We are conducting a study aimed at reducing the chances that acute pancreatitis will become chronic. We think that simvastatin may reduce the inflammation and scarring of the pancreas, which happens in people with recurrent pancreatitis. This may lead to a reduced risk of chronic pancreatitis and pancreatic cancer.
You may be eligible for this study if you:
*Have had more than one episode of pancreatitis in the past 12 months
*Have not used statin medications before
You may be compensated up to $500 for your participation in this study.
For more information: https://www.nucancerprevention.org/pancreas
TITLE: Chronic Pancreatitis Trial – Kangen Pharmaceuticals
If you or someone you love is 18 years of age or older and diagnosed with Chronic Pancreatitis, you may qualify for a clinical trial. CLICK HERE to answer a few simple questions about your Chronic Pancreatitis and see if there is a site near you. Eligible participants will receive study related treatment at no charge and will also receive compensation for their time and travel.
Please see below for more details on:
This listing includes government-funded clinical research studies being conducted by the various National Institutes of Health
Register your email address to be notified when new pancreas disease trials are posted to the database.
This is a comprehensive listing of drugs that have recently been approved by the Food and Drug Administration. The drugs are organized by therapeutic area.
This directory provides detailed profiles of hundreds of clinical research centers organized geographically by state, city and center name.
Here you’ll find links to news articles and reports on recent advances in clinical research. This section is updated weekly and the information has been published in CenterWatch publications during the past weeks. There may not always be gastroenterology-related material included.
NMT Weekly Trial Results database is provides easy access to information about the results of recently completed and ongoing clinical trials. It is based on published materials from conferences, journals and company reports. The trial results summaries typically include the name and phase of the drug, the company sponsoring the research, and information on how well the drug has performed.
Contains a variety of reports, brochures and publications that patients and their advocates can use to learn more about the clinical trials industry and how to identify and volunteer for clinical trials.